| A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis (NCT07688772) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-08-11 |
| A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-Severe Ulcerative Colitis (NCT07758101) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-08-01 |
| A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy Adults (NCT07749651) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-08-01 |
| Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis (NCT07719530) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-08-01 |
| A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Injection in Patients With Plaque Psoriasis (NCT07758075) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-08-01 |
| A Clinical Trial to Evaluate the Efficacy and Safety of HRS-9821 Inhalation Suspension in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (NCT07640451) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-07-20 |
| A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPD (NCT07567872) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-07-09 |
| A Study Comparing a Pre-filled Safety Syringe and an Autoinjector for SHR-1703 Injection in Healthy Participants (NCT07701239) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-07-01 |
| A Phase II Study of SHR-2173 Injection in Patients With Myasthenia Gravis (NCT07622342) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-06-01 |
| Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects (NCT07229716) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-04-04 |
| A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus (NCT07299422) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-04-03 |
| A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis (NCT07309055) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-03-21 |
| A Study of SHR-2173 in Participants With Primary IgA Nephropathy (NCT07354932) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-03-09 |
| A Study to Evaluate SHR-1139 Injection in Patients With Pyoderma Gangrenosum (NCT07444684) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-03-05 |
| A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis (NCT07233655) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-01-19 |
| Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy (NCT07289763) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-12-31 |
| A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis (NCT07232576) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-12-01 |
| A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis (NCT07229742) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-11-22 |
| Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia (NCT07206758) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-11-12 |
| A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis (NCT07211542) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-11-07 |
| The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects (NCT07200596) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-10-08 |
| A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma (NCT07098403) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-09-03 |
| Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps (NCT07132827) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-08-28 |
| A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder for Inhalation and Inhalation Suspension Administered in Healthy Subjects and Multiple Doses in Patients With COPD. (NCT07116915) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-08-11 |
| A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis (NCT07091357) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-08-06 |
| A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors (NCT06993116) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-06-09 |
| A Trial of HRS-9813 Capsule and Tablet in Healthy Subjects (NCT06939504) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-05-04 |
| A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy Subjects (NCT06883695) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-04-08 |
| Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma (NCT06940700) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-04-01 |
| A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis (NCT06875934) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-03-28 |
| A Trial of HRS-9813 in Healthy Subjects (NCT06821464) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-02-17 |
| Pharmacokinetics, Pharmacodynamics, Safety, and Preliminary Efficacy of Subcutaneous Injection of SHR-1905 in Adolescent Asthmatic Subjects - an Open-label, Single-dose Phase II Clinical Study (NCT06786455) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2025-01-23 |
| A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic Dermatitis (NCT06713499) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2024-12-18 |
| A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of SHR-2173 in Patients With Systemic Lupus Erythematosus (NCT06955598) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2024-11-24 |
| A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic Asthma (NCT06653322) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2024-11-21 |
| A Trial of HRS-9813 in Healthy Volunteers (NCT06514963) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2024-07-24 |
| A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients (NCT06441812) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2024-07-19 |
| A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque Psoriasis (NCT07051538) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2024-06-26 |
| Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis (NCT06468956) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2024-06-14 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-4597 Inhalation in Healthy Subjects and Asthmatic Patients (NCT06385964) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2024-05-07 |
| Phase I Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Subcutaneous Injection of SHR-2173 in Healthy Subjects (NCT06995001) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2024-04-28 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3032 in Healthy Subjects (NCT06090799) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2023-11-29 |
| A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA） (NCT05979051) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2023-11-16 |
| Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (NCT05891483) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2023-09-04 |
| A Phase I Study of SHR -2001 in Healthy Subjects (NCT05942612) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2023-07-19 |
| Safety and Tolerance of Increased Doses of SHR-2106 Injection in Healthy Subjects (NCT05948059) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2023-07-11 |
| Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy (NCT05847920) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2023-06-04 |
| Study on Intravenous Injection of SHR-1906 in the Treatment of Idiopathic Pulmonary Fibrosis (NCT05722964) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2023-03-29 |
| A Study to Assess the Efficacy and Tolerance of HRS-2261 in Subjects With Refractory Chronic Cough (NCT05733533) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2023-03-09 |
| Study on Single and Multiple Atomization Inhalation of HRS-9821 Suspension for Inhalation in Healthy Subjects and COPD Patients (NCT05622864) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2023-01-12 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy Subject (NCT05398510) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2022-06-30 |
| A Trial of HRS-2261 in Healthy Subjects After Single and Multiple Oral Administration (NCT05274516) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2022-03-28 |
| A Trial of SHR - 1906 in Healthy Subjects (NCT04986540) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2021-08-10 |